Stock Scorecard



Stock Summary for Kinnate Biopharma Inc (KNTE) - $2.66 as of 3/27/2024 9:06:54 PM EST

Total Score

12 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for KNTE

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for KNTE

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for KNTE

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for KNTE

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for KNTE

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. ( NYSE - AGTI ) , Landos Biopharma, Inc. ( Nasdaq - LABP ) , Fusion Pharmaceuticals Inc. ( Nasdaq - FUSN ) , Kinnate Biopharma Inc. ( Nasdaq - KNTE ) 3/25/2024 3:09:00 PM
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, SCTL, KNTE - Kinnate Biopharma ( NASDAQ:KNTE ) , Whole Earth Brands ( NASDAQ:FREE ) 3/20/2024 11:49:00 AM
XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc. - XOMA ( NASDAQ:XOMA ) , Kinnate Biopharma ( NASDAQ:KNTE ) 3/19/2024 8:05:00 PM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Pharmaceuticals Inc. ( Nasdaq - FUSN ) , Whole Earth Brands, Inc. ( Nasdaq - FREE ) , Kinnate Biopharma Inc. ( Nasdaq - KNTE ) , Societal CDMO Check Corp. ( Nasdaq - SCTL ) 3/19/2024 4:00:00 PM
INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - TGAN, HMST, KNTE 3/18/2024 9:21:00 PM
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates KNTE, DOOR, HMST - HomeStreet ( NASDAQ:HMST ) , Masonite International ( NYSE:DOOR ) 3/13/2024 9:53:00 PM
INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - KNTE, DOOR, HMST 3/13/2024 9:05:00 PM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Whole Earth Brands, Inc. ( Nasdaq - FREE ) , Kinnate Biopharma Inc. ( Nasdaq - KNTE ) , Societal CDMO Check Corp. ( Nasdaq - SCTL ) , California BanCorp ( Nasdaq - CALB ) 3/13/2024 2:48:00 PM
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value 3/8/2024 12:30:00 PM
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - BATL, MDC, KNTE, INBX 3/7/2024 1:42:00 AM

Financial Details for KNTE

Company Overview

Ticker KNTE
Company Name Kinnate Biopharma Inc
Country USA
Description Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers. The company is headquartered in San Diego, California.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2023
Next Earnings Date 5/9/2024

Stock Price History

Last Day Price 2.66
Last Day Price Updated 3/27/2024 9:06:54 PM EST
Last Day Volume 472,024
Average Daily Volume 507,543
52-Week High 7.18
52-Week Low 1.04
Last Price to 52 Week Low 155.77%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE -4.02
Free Cash Flow Ratio 0.75
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 10.80
Total Cash Per Share 3.55
Book Value Per Share Most Recent Quarter 3.66
Price to Book Ratio 0.73
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 47,166,400
Market Capitalization 125,462,624
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -29.53%
Reported EPS 12 Trailing Months -2.78
Reported EPS Past Year -2.06
Reported EPS Prior Year -2.65
Net Income Twelve Trailing Months -127,154,000
Net Income Past Year -116,271,000
Net Income Prior Year -89,763,000
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet

Total Cash Most Recent Quarter 167,576,000
Total Cash Past Year 201,475,000
Total Cash Prior Year 219,458,000
Net Cash Position Most Recent Quarter 167,176,000
Net Cash Position Past Year 201,075,000
Long Term Debt Past Year 400,000
Long Term Debt Prior Year 400,000
Total Debt Most Recent Quarter 400,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 223,468,000
Total Stockholder Equity Prior Year 319,477,000
Total Stockholder Equity Most Recent Quarter 172,420,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.05
MACD Signal 0.05
20-Day Bollinger Lower Band 2.18
20-Day Bollinger Middle Band 2.43
20-Day Bollinger Upper Band 2.69
Beta 1.34
RSI 66.62
50-Day SMA 2.54
200-Day SMA 0.00

System

Modified 3/26/2024 11:43:44 PM EST